Quest LaboratoriesNSE:QUESTLAB -1.56%44 Days Inventory is 101.68 as of Mar. 2026, which is 49% above its 10-year median of 68.41. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 44/100. The stock has 8 warning signs investors should review. Among 919 Drug Manufacturers companies, Quest Laboratories ranks worse than 92.49% on this metric.
The historical rank and industry rank for Quest Laboratories's Days Inventory or its related term are showing as below:
NSE:QUESTLAB'
s Days Inventory Range Over the Past 10 Years
Min: 7.82 Med: 68.41 Max: 406.73
Current: 406.73
During the past 6 years, Quest Laboratories's highest Days Inventory was 406.73. The lowest was 7.82. And the median was 68.41.
NSE:QUESTLAB's Days Inventory is ranked worse than 92.49% of 919
companies
in the Drug Manufacturers industry
Industry Median: 162.83
vs NSE:QUESTLAB: 406.73
Quest Laboratories's Days Inventory
increased
from Sep. 2023 (0.00) to Mar. 2026 (101.68).
It might indicate that Quest Laboratories's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Quest Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.90.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Quest Laboratories's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.93.
Quest Laboratories (NSE:QUESTLAB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Quest Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Quest Laboratories's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Quest Laboratories Days Inventory Related Terms
Quest Laboratories Days Inventory Historical Data
* Premium members only.
The historical data trend for Quest Laboratories's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QUESTLAB vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Quest Laboratories's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest Laboratories Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's Days Inventory distribution charts can be found below:
* The bar in red indicates where Quest Laboratories's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quest Laboratories (NSE:QUESTLAB) has a Days Inventory of 101.68 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Quest Laboratories and its competitors. This is 49% above median its historical median of 68.41. Over the past decade, Quest Laboratories' Days Inventory has ranged from 7.82 to 406.73. According to the industry distribution chart, Quest Laboratories ranks #850 out of 919 companies in the Drug Manufacturers industry, placing it in the top 92.5%.
Is Quest Laboratories' Days Inventory too high?
Quest Laboratories' current Days Inventory of 101.68 is 49% above median its 10-year median of 68.41. Over the past 10 years, this metric has ranged from a low of 7.82 to a high of 406.73. The Drug Manufacturers industry median Days Inventory is 162.83. Quest Laboratories' value of 101.68 is 37.6% below this industry median. Based on the distribution chart, Quest Laboratories ranks #850 out of 919 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Quest Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Quest Laboratories ranks #850 out of 919 companies for Days Inventory. This places Quest Laboratories in the lower half of its industry. The industry median Days Inventory is 162.83. Quest Laboratories' value of 101.68 is 37.6% below this benchmark. Historically, Quest Laboratories' own Days Inventory has ranged from 7.82 to 406.73 over the past decade. While the company's 10-year median is 68.41 vs. the industry median of 162.83, Quest Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 162.83, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quest Laboratories's current Days Inventory of 101.68 is 37.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Quest Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 162.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest Laboratories's current Days Inventory is 101.68, which is 49% above median its own 10-year median of 68.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Days Inventory of 101.68. The current Days Inventory is 101.68, which is 49% above median its 10-year median of 68.41 and 37.6% below the Drug Manufacturers industry median of 162.83. Quest Laboratories' overall GF Score™ is 44/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Days Inventory is 101.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
44GF Score
Get the complete analysis for NSE:QUESTLAB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QUESTLAB has been successfully added to your 